MSK 01 and 04: NSAIDs Flashcards

1
Q

Describe the actions of NSAIDs.

A

have both peripheral actions (anti-inflammatory, analgesic) and central effects (analgesic, antipyretic)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the mechanism of action of NSAIDs?

A

inhibit biosynthesis of prostaglandins by competitive antagonism of COX1 and COX2 catalytic site

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the mechanism of action of acetylsalicylic acid (ASA)?

A
  • non-competitive inhibitor of COX
  • irreversible acetylation of serine in catalytic site of COX (both COX1 and 2) enzyme mediates anti-prostaglandin action
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the main metabolite of NSAIDs?

A

salicylate

  • weak anti-inflammatory, antipyretic, and analgesic effects as a competitive COX antagonist (reduces prostaglandin synthesis)
  • may also down regulate COX2 gene transcription
  • inhibit platelet aggregation by targeting COX1 in cells and preventing formation of TXA2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the major deleterious effects of NSAIDs and ASA? (4)

A
  • ↑ blood pressure
  • ↓ renal function – prostaglandins regulate renal blood flow and promote Na+ excretion (COX1 and COX2)
  • GI ulceration (COX1) – PGE2 promotes ↓ HCl and ↑ GI mucous production
  • anti-platelet action – slight ↑ in bleeding time, except for ASA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the mechanism of action of celexocib?

A
  • COX2 selective NSAID
  • inhibits biosynthesis of prostaglandins by blocking COX2 with less effect on COX1 (dose related)
  • not very selective (10-20x more selective for COX2), high dose celecoxib loses its selectivity for COX2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the adverse effects of celecoxib?

A
  • similar or greater incidence of cardiovascular and renal side effects
  • at lower doses, decreased ulcer risk and no effect on platelet aggregation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is gastric damage caused by NSAIDs due to?

A

in part to acidity of carboxylate functionality, and in part to COX-1 inhibition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Compare salicylic acid and ASA.

A
  • pseudo-6-membered ring in SA stabilizes deprotonated/ionized form
  • pseudo-6-membered ring of ASA stabilizes protonated form
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the mechanism of action of aspirin?

A
  • COX inhibition
  • the only NSAID that covalently modifies COX by acetylating Ser530 (COX-1)/Ser516 (COX-2), which blocks COX active site and interfere with arachidonate binding
  • much more potent against COX-1 than COX-2
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are aryl alkanoic acid NSAIDs?

A

contain acetic acid or proprionic acid attached to aromatic or heteroaromatic group

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which acetic acid derivatives exhibit more COX1 selectivity?

A

indomethacin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Which acetic acid derivatives exhibit more COX2 selectivity?

A
  • Z-sulindac
  • sulindac sulfide
  • diclofenac
  • etodolac
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe the structural and functional features of diclofenac.

A

o-Chloro groups force twisting – effect important for COX binding

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What is nabumetone?

A
  • naphthylalkanone derivative
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the mechanism of action of nabumetone?

A
  • non-selective COX-1 and COX-2 inhibitor
  • converted to its active metabolite 6-MNA by liver enzyme CYP3A4
17
Q

What are the advantages of nabumetone? (2)

A
  • reduces possibility of GI side effects commonly associated with acidity of NSAIDs (no primary insult of GI tract)
  • ineffective as COX-1 inhibitor in gastric mucosa (no secondary insult of GI tract)
18
Q

Compare the potency of aspirin, diclofenac, and nabumetone?

A

aspirin < nabumetone < diclofenac

19
Q

What are some proprionic acid derivatives?

A
  • flurbiprofen
  • ketoprofen
  • naproxen
  • ibuprofen
20
Q

Describe the structure of proprionic acid derivatives.

A
  • pharmacological activity resides in S(+) enantiomer, but most drugs are marketed as racemic
  • epimerization of R(-) to S(+) enantiomer occurs rapidly in vivo
21
Q

What is the mechanism of action of proprionic acid derivatives?

A

exhibit mostly COX-1 selectivity

22
Q

Compare proprionic acid NSAIDs to acetic acid NSAIDs.

A

generally less acidic due to modest EDG effect of methyl group

23
Q

What is ketorolac?

A

pyrrolizine carboxylic acid derivative

24
Q

What is ketorolac structurally similar to?

A
  • indomethacin
  • ketoprofen
25
Q

What is the mechanism of action of ketorolac?

A
  • high degree of selectivity toward COX-1 over COX-2
  • primarily for analgesic activity – similar to centrally acting analgesics (widely accepted as alternative to narcotic analgesia)
26
Q

What are oxicams?

A
  • enolic class of NSAIDs generally indicated for long-term use in rheumatoid arthritis and osteoarthritis
  • unusually acidic compounds
27
Q

What are some oxicams?

A
  • piroxicam
  • meloxicam
  • tenoxicam
28
Q

What is the mechanism of action of oxicams?

A
  • highly potent
  • exhibits selectivity toward COX-2 over COX-1
29
Q

What occurs at the R1 position of oxicams?

A

N-heterocylic carboxamides are more acidic than corresponding N-aryl carboxamides

30
Q

What is the acidity of oxicams due to?

A

stabilization of enolate anion by adjacent heterocyclic nitrogen atom through formation of two tautomers

  • tautomers reveal anion stabilization by 2 pseudo-6-membered rings
31
Q

What is the general idea behind COX2 selectivity?

A

provide therapeutic advantage over older NSAIDs by reducing inflammatory response (COX-2) and not interfering with GI-protective functions of COX-1

32
Q

Describe the structure of selective COX2 inhibitors compared to other NSAIDs.

A

contain sulfonamide, sulfonyl, or related group in place of carboxylic acid group

33
Q

What were selective COX2 inhibitors designed to do?

A

take advantage of larger substrate binding site of COX-2 as compared to COX-1

  • COX-1 has Ile at position 523 in active site that restricts access to large rigid substrates
  • COX-2 has Val at same position, which is smaller by one methyl group
  • when selective COX-2 inhibitors are docked onto COX-1, sulfonamide/sulfonyl groups display repulsive interaction with Ile523, but not with smaller Val509 in COX-2
  • these inhibitors fit into, and interact with, binding site of COX differently than other NSAIDs
34
Q

What is the apparent consequence of selective COX2 inhibition?

A

significant reduction in production of prostacyclins (PGI2 suppression can cause elevated BP, accelerated atherogenesis, etc.)

  • whereas COX-1 production of TXA2 (inducer of platelet aggregation) is unaffected